Thyrotoxic periodic paralysis, a series of cases

Background: Thyrotoxic periodic paralysis (TPP) is a rare but dangerous complication observed in thyrotoxic patients, where a clinical presentation of muscle compromise common in channelopathies occurs. Objective: The objective of the study was to present 2 clinical cases of patients who presented P...

Full description

Autores:
Bustos-Sánchez, José Luis
GUERRA GUERRA, LUISA IVONNE
Penagos Martínez, Iván Andrés
Núñez Mesa, Jeisson Steven
Vargas Rodríguez, Ledmar Jovanny
Tipo de recurso:
Article of investigation
Fecha de publicación:
2024
Institución:
Universidad de Ciencias Aplicadas y Ambientales U.D.C.A
Repositorio:
Repositorio Institucional UDCA
Idioma:
eng
OAI Identifier:
oai:repository.udca.edu.co:11158/5750
Acceso en línea:
https://repository.udca.edu.co/handle/11158/5750
https //doi.org/10.1016/j.neuarg.2024.04.003
Palabra clave:
610 - Medicina y salud
Tirotoxicosis
Parálisis
Hipopotasemia
Hipertiroidismo
Arreflexia
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-sa/4.0/legalcode.es
Description
Summary:Background: Thyrotoxic periodic paralysis (TPP) is a rare but dangerous complication observed in thyrotoxic patients, where a clinical presentation of muscle compromise common in channelopathies occurs. Objective: The objective of the study was to present 2 clinical cases of patients who presented PPT. Clinical cases: Case 1: A 31-year-old male patient, with a progressive picture of asthenia, cramps, decreased muscle strength in the 4 extremities with greater involvement of the lower extremities, gait slower than usual, and tremor over the course of 4 days distal postural position in all 4 extremities, not triggered by any physical activity or stressful situation. Case 2: A 25-year-old male patient, with a 3-day progression of weakness in the 4 extremities, with a greater predominance in the lower extremities associated with myalgia in the thighs and calves, not triggered by any physical activity or stressful situation. Conclusion: In the cases presented, the patients reported hypokalemia and uncontrolled hyperthyroidism in the paraclinical tests, so it was decided to perform management with K+ replacement to prevent rebound hyperkalemia and β blockers, with which an adequate evolution was obtained, concluding that it presented with PPT. This pathological entity should be suspected in patients with thyrotoxicosis, hypokalemia, and sudden proximal symmetric muscle weakness of the lower extremities.